Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years

Khalid Hussain AL-Qahtani,1 Mutahir A Tunio,2 Mushabbab Al Asiri,2 Yasser Bayoumi,3 Ali Balbaid,2 Naji J Aljohani,4 Hanadi Fatani5 1Department of Otolaryngology-Head & Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of Radiation Oncology, Comprehen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: AL-Qahtani KH, Tunio MA, Asiri MA, Bayoumi Y, Balbaid A, Aljohani NJ, Fatani H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/ff6fa28af47843d2b0fe0b45c897b11f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ff6fa28af47843d2b0fe0b45c897b11f
record_format dspace
spelling oai:doaj.org-article:ff6fa28af47843d2b0fe0b45c897b11f2021-12-02T01:05:22ZComparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years1178-1998https://doaj.org/article/ff6fa28af47843d2b0fe0b45c897b11f2016-08-01T00:00:00Zhttps://www.dovepress.com/comparative-clinicopathological-and-outcome-analysis-of-differentiated-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Khalid Hussain AL-Qahtani,1 Mutahir A Tunio,2 Mushabbab Al Asiri,2 Yasser Bayoumi,3 Ali Balbaid,2 Naji J Aljohani,4 Hanadi Fatani5 1Department of Otolaryngology-Head & Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia; 3Department of Radiation Oncology, NCI, Cairo University, Cairo, Egypt; 4Department of Endocrinology and Thyroid Oncology, 5Histopathology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia Introduction: The aim of this study was to evaluate the treatment outcomes of differentiated thyroid cancer in Saudi patients aged above 60 years. Materials and methods: Comparative analysis was performed in 252 patients aged 46–60 years (Group A) and 118 patients aged above 60 years (Group B), who had thyroidectomy, radioactive iodine-131, and thyroid-stimulating hormone suppression therapy between July 2000 and December 2012. Different clinicopathological features, treatment, complications, disease-free survival, and overall survival rates were compared. Results: Mean age of patients in Group A was 51.9 years (range: 46–60), and mean age of those in Group B was 68.6 years (range: 62–97). Group B patients had higher positive lymph nodes (43.2%), P=0.011. The frequency of extrathyroidal extension, multifocality, and lymphovascular space invasion was seen more in Group B than in Group A. Postsurgical complications (permanent hypoparathyroidism, bleeding, and wound infections) were also seen more in Group B (P=0.043, P=0.011, and P=0.021, respectively). Group B patients experienced more locoregional recurrences (11.0%, P=0.025); similarly, more distant metastases were observed in Group B (15.3%, P=0.003). The 10-year disease-free survival rates were 87.6% in Group A and 70.8% in Group B (P<0.0001). Conclusion: Differentiated thyroid cancer in patients aged above 60 years are more aggressive biologically and associated with a worse prognosis, and the morbidity is significantly high as compared to patients aged below 60 years. Keywords: differentiated thyroid cancers, patients aged above 45 years, aged above 60 years, clinicopathological characteristics, treatment outcomes, elderly patients, aged below 60 years, comparative analysisAL-Qahtani KHTunio MAAsiri MABayoumi YBalbaid AAljohani NJFatani HDove Medical PressarticleDifferentiated thyroid cancerspatients aged above 45 yearsaged above 60 yearsage below 60 yearsclinicopathological characteristicstreatment outcomeselderly patients. comparative analysisGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 11, Pp 1169-1174 (2016)
institution DOAJ
collection DOAJ
language EN
topic Differentiated thyroid cancers
patients aged above 45 years
aged above 60 years
age below 60 years
clinicopathological characteristics
treatment outcomes
elderly patients. comparative analysis
Geriatrics
RC952-954.6
spellingShingle Differentiated thyroid cancers
patients aged above 45 years
aged above 60 years
age below 60 years
clinicopathological characteristics
treatment outcomes
elderly patients. comparative analysis
Geriatrics
RC952-954.6
AL-Qahtani KH
Tunio MA
Asiri MA
Bayoumi Y
Balbaid A
Aljohani NJ
Fatani H
Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
description Khalid Hussain AL-Qahtani,1 Mutahir A Tunio,2 Mushabbab Al Asiri,2 Yasser Bayoumi,3 Ali Balbaid,2 Naji J Aljohani,4 Hanadi Fatani5 1Department of Otolaryngology-Head & Neck Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2Department of Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia; 3Department of Radiation Oncology, NCI, Cairo University, Cairo, Egypt; 4Department of Endocrinology and Thyroid Oncology, 5Histopathology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia Introduction: The aim of this study was to evaluate the treatment outcomes of differentiated thyroid cancer in Saudi patients aged above 60 years. Materials and methods: Comparative analysis was performed in 252 patients aged 46–60 years (Group A) and 118 patients aged above 60 years (Group B), who had thyroidectomy, radioactive iodine-131, and thyroid-stimulating hormone suppression therapy between July 2000 and December 2012. Different clinicopathological features, treatment, complications, disease-free survival, and overall survival rates were compared. Results: Mean age of patients in Group A was 51.9 years (range: 46–60), and mean age of those in Group B was 68.6 years (range: 62–97). Group B patients had higher positive lymph nodes (43.2%), P=0.011. The frequency of extrathyroidal extension, multifocality, and lymphovascular space invasion was seen more in Group B than in Group A. Postsurgical complications (permanent hypoparathyroidism, bleeding, and wound infections) were also seen more in Group B (P=0.043, P=0.011, and P=0.021, respectively). Group B patients experienced more locoregional recurrences (11.0%, P=0.025); similarly, more distant metastases were observed in Group B (15.3%, P=0.003). The 10-year disease-free survival rates were 87.6% in Group A and 70.8% in Group B (P<0.0001). Conclusion: Differentiated thyroid cancer in patients aged above 60 years are more aggressive biologically and associated with a worse prognosis, and the morbidity is significantly high as compared to patients aged below 60 years. Keywords: differentiated thyroid cancers, patients aged above 45 years, aged above 60 years, clinicopathological characteristics, treatment outcomes, elderly patients, aged below 60 years, comparative analysis
format article
author AL-Qahtani KH
Tunio MA
Asiri MA
Bayoumi Y
Balbaid A
Aljohani NJ
Fatani H
author_facet AL-Qahtani KH
Tunio MA
Asiri MA
Bayoumi Y
Balbaid A
Aljohani NJ
Fatani H
author_sort AL-Qahtani KH
title Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_short Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_full Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_fullStr Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_full_unstemmed Comparative clinicopathological and outcome analysis of differentiated thyroid cancer in Saudi patients aged below 60 years and above 60 years
title_sort comparative clinicopathological and outcome analysis of differentiated thyroid cancer in saudi patients aged below 60 years and above 60 years
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/ff6fa28af47843d2b0fe0b45c897b11f
work_keys_str_mv AT alqahtanikh comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT tunioma comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT asirima comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT bayoumiy comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT balbaida comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT aljohaninj comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
AT fatanih comparativeclinicopathologicalandoutcomeanalysisofdifferentiatedthyroidcancerinsaudipatientsagedbelow60yearsandabove60years
_version_ 1718403355416461312